Through
4/26
Penn researchers say the new technique for making human artificial chromosomes from single, long constructs of designer DNA will allow for more efficient laboratory research.
The Presidential Penn Compact Associate Professor in Chemical and Biomolecular Engineering aims to make gene editing tools like CRISPR more accurate, and encourage first generation students along the way.
Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.
Penn Engineering researchers have invented a new way to synthesize the key chemical components of lipid nanoparticles that help protect and deliver medicinal payloads.
Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy.
Penn engineers are opening new avenues for detecting the proteins implicated in diseases like Alzheimer’s and testing new treatments.
The Stephenson Foundation Term Assistant Professor of Innovation and her lab members work to engineer nanoparticles as medicinal vehicles to fit directly into a single cell.
A team of researchers in the School of Engineering and Applied Sciences has devised a method to deliver mRNA into the brain using lipid nanoparticles, potentially advancing treatments for Alzheimer’s disease and seizures.
A new platform to engineer adoptive cell therapies for specific autoimmune diseases has the potential to create therapies for allergies, organ transplants, and more.
An interdisciplinary team of researchers in the School of Engineering and Applied Science, Perelman School of Medicine, and School of Arts & Sciences has developed a technique that allows for characterization of both individual carrier and cargo for clinically important molecules.
A lab at the School of Engineering and Applied Science led the development of a COVID test made from bacterial cellulose, an organic compound.
FULL STORY →
Michael Mitchell of the School of Engineering and Applied Science and colleagues have constructed a model that could potentially allow drug transporters to bypass the blood-brain barrier.
FULL STORY →
David Meaney of the School of Engineering and Applied Science oversees an undergraduate bioengineering lab that uses cockroach legs to teach students to work with human prostheses.
FULL STORY →
Preclinical research by Robert Mauck of the Perelman School of Medicine, Thomas Schaer of the School of Veterinary Medicine, and Ana Peredo, a Ph.D. graduate of the School of Engineering and Applied Science, reveals how a biologic patch activated by natural motion could become a key tool for repairing herniated discs in the back and relieving pain.
FULL STORY →
A study by César de la Fuente of the Perelman School of Medicine and colleagues used AI to recreate molecules from ancient humans that could be potential candidates for antimicrobial treatments.
FULL STORY →
Research from Michael Mitchell of the School of Engineering and Applied Science has developed a new method to stop cytokine release during CAR T cell therapy, preventing some of its more dangerous side effects.
FULL STORY →